文献速递糖尿病

1型糖尿病中抗原经验B细胞CXCR3表达系统性失调

CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetes.
PubMed 文献 · Diabetologia · 2025-11-22

本研究比较新发与长期1型糖尿病患者及非糖尿病供者外周血B细胞CXCR3表达,并用尸检胰腺组织免疫荧光评估。长期患者抗原经验B细胞CXCR3表达降低但仍对IFNγ有反应;新发患者IFNγ刺激后CXCR3表达升高;新发年轻供者胰腺B细胞缺乏CXCR3,但存在CXCR3+CD20+CD8+T细胞。

要点

  • 长期1型糖尿病患者抗原经验B细胞CXCR3表达降低。
  • 新发1型糖尿病B细胞经IFNγ刺激后CXCR3表达高于非糖尿病供者。
  • 新发年轻供者胰腺B细胞缺乏CXCR3,但CD8+T细胞表达CXCR3和CD20。

核心结论

  • 1型糖尿病进展过程中抗原经验B细胞的CXCR3反应失调。

研究设计与样本

  • 获取新发和长期1型糖尿病患者及年龄性别匹配的非糖尿病供者外周血样本,分离PBMC进行多参数流式细胞术和功能细胞培养。
  • 从Exeter Archival Diabetes Biobank获取人尸检胰腺组织,用免疫荧光染色评估CXCR3表达。

主要发现

  • 长期1型糖尿病个体抗原经验B细胞CXCR3表达降低,但B细胞仍对IFNγ有反应。
  • 新诊断个体经IFNγ处理后B细胞CXCR3表达较非糖尿病供者增加。
  • 年轻新发供者尸检胰腺B细胞缺乏CXCR3表达,但检测到CXCR3+CD20+CD8+T细胞群体,其循环对应细胞CXCR3表达增加。

临床怎么用

  • 提示CXCR3在B细胞上的表达随1型糖尿病病程动态变化,可作为免疫监测的候选标志。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The chemokine receptor C-X-C chemokine receptor type 3 (CXCR3) is a key chemoattractant molecule that facilitates the migration of activated T cells to the pancreas, leading to beta cell death. In this study, we investigated CXCR3 responses in B cells during type 1 diabetes progression. METHODS: Peripheral blood samples were obtained from individuals with recent-onset and long-duration type 1 diabetes, who were age- and sex-matched to non-diabetic donors. We isolated peripheral blood mononuclear cells (PBMCs) and examined changes in CXCR3 expression on lymphocytes from donors, performing multiparameter flow cytometry and functional cell culture assays. Human post-mortem pancreatic tissue was obtained from the Exeter Archival Diabetes Biobank. Immunofluorescence staining was used to assess CXCR3 expression in pancreatic tissues. RESULTS: We observed reduced CXCR3 expression on antigen-experienced B cells in individuals with a long duration of type 1 diabetes, although B cells remained responsive to IFNγ. In individuals who were recently diagnosed, IFNγ treatment resulted in increased CXCR3 expression compared with B cells from non-diabetic donors. B cells in pancreases that were recovered post-mortem from young recent-onset donors lacked CXCR3 expression, but co-staining to detect CD8+ T cells revealed a CXCR3+CD20+CD8+ T cell population, with their circulating counterpart showing increased CXCR3 expression. CONCLUSIONS/INTERPRETATION: We conclude that the CXCR3 response in antigen-experienced B cells is dysregulated during the progression of type 1 diabetes. CXCR3 expression is limited in CD20+ B cells in pancreases from recent-onset individuals diagnosed with type 1 diabetes under 7 years of age, but evident on CD8+ T cells that express CD20.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Boldison J, Leete P, Robinson EJ, et al. CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetes. Diabetologia. 2025. PMID: 41273416. doi:10.1007/s00125-025-06608-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。